| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/16/1995 | CA2145767A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 02/16/1995 | CA2144523A1 High molecular weight desulphatohirudin |
| 02/15/1995 | EP0638645A1 Human TRH receptor, its production and use |
| 02/15/1995 | EP0638644A1 Receptors of interleukin-12 and antibodies |
| 02/15/1995 | EP0638316A1 Recombinant adenovirus vaccines |
| 02/15/1995 | EP0638175A1 In vitro test for helicobacter pylori |
| 02/15/1995 | EP0638174A1 Measles virus-specific antibody detection using recombinant measles proteins. |
| 02/15/1995 | EP0638172A1 METHODS AND COMPOSITIONS FOR MONITORING CELLULAR PROCESSING OF $g(b)-AMYLOID PRECURSOR PROTEIN |
| 02/15/1995 | EP0638126A1 Inhibitory factor |
| 02/15/1995 | EP0638124A1 Oral infection of insect larvae with pre-occluded baculovirus particles |
| 02/15/1995 | EP0638122A1 Cdna sequence of dengue virus serotype 1 (singapore strain) |
| 02/15/1995 | EP0638093A1 Novel plant virus sequences |
| 02/15/1995 | EP0638092A1 Synthetic peptide vaccines for dental caries |
| 02/15/1995 | EP0638091A1 Improved solubilization and stabilization of factor viii complex |
| 02/15/1995 | EP0638088A1 Hybrid human/porcine factor viii |
| 02/15/1995 | EP0638085A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 02/15/1995 | EP0638067A1 Novel propoxyphene derivatives and protein and polypeptide propoxyphene derivative conjugates and labels |
| 02/15/1995 | EP0637970A1 Polyamino acid superabsorbents |
| 02/15/1995 | EP0637968A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 02/15/1995 | EP0637963A1 Cd28 pathway immunoregulation |
| 02/15/1995 | EP0587780B1 Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits |
| 02/15/1995 | EP0573538B1 Peptides for treatment |
| 02/15/1995 | EP0524172B1 A method for isolating factor viii |
| 02/15/1995 | EP0377023B1 Process for recovering refractile bodies containing heterologous proteins from microbial hosts |
| 02/15/1995 | EP0175787B1 RECOMBINANT HERPES SIMPLEX gB-gD VACCINE |
| 02/15/1995 | CN1098744A Deoxyribonucleic acids |
| 02/15/1995 | CN1098742A Novel aminopeptidase, processes for the preparation of aminopeptidase and protein therefrom |
| 02/15/1995 | CN1027640C Process for the production of new trifluoromethyl ketone substituted peptide derivatives |
| 02/14/1995 | US5389623 Redox carriers for brain-specific drug delivery |
| 02/14/1995 | US5389612 Phosphonic peptide inhibitors of bacterial collagenases |
| 02/14/1995 | US5389609 Antifungal preparations, and process for making such preparations |
| 02/14/1995 | US5389543 Cloned genes encoding the D1 dopamine receptor |
| 02/14/1995 | US5389540 Employing a DNA coding sequence having a (G+C) content that has been increased in the region from nucleotide 410 to the 3' end of the coding sequence relative to wild-type DNA sequence |
| 02/14/1995 | US5389533 Immobilization of biochemical substances on a carrier containing a layer of an olefinic - unsaturated, epoxyfunctional polyether |
| 02/14/1995 | US5389531 Methods to replicate DNA in vitro using PRD1-catalyzed DNA replication systems |
| 02/14/1995 | US5389529 Gene comprising DNA molecule encoding signal sequence altered to encode fourteen hydrophobic amino acids in core region |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389527 DNA encoding mammalian phosphodiesterases |
| 02/14/1995 | US5389526 Producing polypeptides which facilitate extrachromosomal replication or recominant plasmid carrying variety of genes and promoter sequences; culturing |
| 02/14/1995 | US5389525 DNA-molecules coding for FMDH control regions and structural gene for a protein having FMDH-activity and their use thereof |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | US5389517 Specific antibodies against the DNA-binding domain of and immunoassays to determine the presence and functional status of estrogen receptor proteins |
| 02/14/1995 | US5389514 Transfection; hybridization; converting uridine to cytidine by means of nuclear extract obtained from human or mammal or flies cells |
| 02/14/1995 | US5389381 Administering superoxide dismutase bound to low diol polyoxyethylene glycol with buffers and protective cyclodextrins |
| 02/14/1995 | US5389069 Method and apparatus for in vivo electroporation of remote cells and tissue |
| 02/14/1995 | CA2129763A1 Insulin formulation |
| 02/14/1995 | CA1334390C Glycoprotein growth modulation materials |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/12/1995 | CA2130202A1 Recombinant adenovirus vaccines |
| 02/11/1995 | CA2130210A1 Human trh receptor, its production and use |
| 02/10/1995 | EP0661988A4 Composition and treatment with biologically active peptides and chelating agents. |
| 02/10/1995 | CA2129812A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria in which they are present, and their use |
| 02/09/1995 | WO1995004282A1 Immunoassay for detecting collagen or collagen fragments |
| 02/09/1995 | WO1995004158A1 Use of heparanase to identify and isolate anti-heparanase compound |
| 02/09/1995 | WO1995004152A1 Dna, constructs, cells and plants derived therefrom |
| 02/09/1995 | WO1995004150A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 02/09/1995 | WO1995004147A1 Recombinant constructs using replacement sequences in hypervariable regions |
| 02/09/1995 | WO1995004146A2 Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects |
| 02/09/1995 | WO1995004145A1 Novel b. burgdorferi polypeptides |
| 02/09/1995 | WO1995004144A1 Dna encoding a human calcium channel alpha-1e subunit |
| 02/09/1995 | WO1995004143A1 Creating novel hematopoietic cell lines by expressing altered retinoic acid receptors |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004078A1 Cell adhesion protein complexes with copper |
| 02/09/1995 | WO1995004076A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995004074A1 THE ESCHERICHIA COLI csrA GENE, PROTEIN ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 02/09/1995 | WO1995004073A1 Type-2 angiotensin ii receptor and gene |
| 02/09/1995 | WO1995004071A1 Process for the continuous removal of products from high pressure systems |
| 02/09/1995 | WO1995004068A1 Oligomers for modulating human immunodeficiency virus |
| 02/09/1995 | WO1995004067A1 Markers for detection of chromosome 16 rearrangements |
| 02/09/1995 | WO1995003831A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | WO1995003828A1 Single-chain immunotoxin compositions and methods for preventing secondary cataracts |
| 02/09/1995 | WO1995003827A1 Method for treating multiple sclerosis |
| 02/09/1995 | WO1995003825A1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/09/1995 | WO1995003821A1 Prosaposin and cytokine-derived peptides as therapeutic agents |
| 02/09/1995 | WO1995003820A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | WO1995003819A1 Regulation of oxidative burst using lmwg-derived peptides and analogs |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003814A1 Cellular vaccine and methods of use for the treatment of solid tumor malignancies |
| 02/09/1995 | WO1995003813A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | WO1995003777A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 02/09/1995 | WO1995000645A3 Process for producing relaxin |
| 02/09/1995 | WO1994029450A3 Novel, recombinantly produced spider silk analogs |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168647A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2168008A1 Escherichia coli csra gene, protein encoded thereby, and methods of use thereof |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | CA2167730A1 Synthetic multiple tandem repeat mucin and mucin-like peptides and uses thereof |
| 02/09/1995 | CA2167533A1 Novel eimeria antibodies and antigens and methods of using the same |
| 02/09/1995 | CA2167496A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/09/1995 | CA2166995A1 Transgenic, cross-linked hemoglobin |
| 02/08/1995 | EP0637631A2 Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637592A1 Processes of producing amylase inhibitors |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |